neratinib

CHMP reverses course on neratinib, handing Puma an unexpected win on European marketing vote — shares soar
Endpoints
Tue, 06/26/18 - 11:58 am
Puma Biotechnology
Europe
CHMP
EMA
neratinib
Nerlynx
breast cancer
Puma Biotechnology shares tank after CHMP looks ready to hit a red light on neratinib
Endpoints
Wed, 01/24/18 - 09:13 am
Puma Biotechnology
CHMP
neratinib
cancer
Europe
Puma granted broad label for neratinib after FDA OK
BioPharma Dive
Wed, 07/19/17 - 09:31 am
Puma Biotechnology
neratinib
breast cancer
Nerlynx
Puma wins big FDA OK for neratinib after running the gamut with investors
Endpoints
Mon, 07/17/17 - 06:50 pm
Puma Biotechnology
neratinib
breast cancer
Nerlynx
Puma's FDA Decider And Semaglutide's Head-To-Head Battle
Seeking Alpha
Mon, 07/10/17 - 11:09 am
Puma Biotechnology
FDA
Novo Nordisk
Nerlynx
neratinib
semaglutide
5 Biotech Stocks With Major Catalysts in July
Motley Fool
Wed, 06/28/17 - 11:03 pm
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
Prescribed Reading: FDA on a roll, while pharma continues sell off
BioPharma Dive
Tue, 05/30/17 - 10:07 am
FDA
Roche
Ocrevus
Puma Biotechnology
neratinib
Novartis
FDA Panel Votes 12 To 4 to Approve Puma's Breast Cancer Drug
Forbes
Thu, 05/25/17 - 08:51 am
FDA
Puma Biotechnology
breast cancer
advisory panels
neratinib
Puma Biotechnology FDA Live Blog
Forbes
Wed, 05/24/17 - 10:39 am
FDA
Puma Biotechnology
advisory panels
neratinib
breast cancer
Puma shares jump 40% after FDA review but brief leaves scope for AdComm grilling and neratinib rejection
Fierce Biotech
Tue, 05/23/17 - 08:13 am
Puma Biotechnology
neratinib
breast cancer
FDA review raises some serious questions for Puma, but shares rocket up on positive notes
Endpoints
Mon, 05/22/17 - 10:21 am
FDA
Puma Biotechnology
neratinib
breast cancer
advisory panels
Shortened FDA Advisory Panel Is Bad Omen for Puma Bio's Controversial Breast Cancer Drug
TheStreet.com
Tue, 04/18/17 - 09:13 pm
FDA
advisory panels
Puma Biotechnology
neratinib
breast cancer
Top Biotech Stocks With FDA Decisions in 2017
Motley Fool
Fri, 03/3/17 - 09:42 am
FDA
Flexion
Zilretta
knee pain
osteoarthritis
neratinib
Puma Biotechnology
breast cancer
Portola
betrixaban
bloodthinners
Puma shares ripped after a new grade 3 diarrhea threat is highlighted in an abstract
Endpoints
Mon, 11/14/16 - 10:41 pm
Puma Biotechnology
neratinib
Puma Bio's Desperate Money Grab Signals Breast Cancer Drug Trouble
TheStreet.com
Thu, 10/20/16 - 03:31 pm
Puma Biotechnology
breast cancer
neratinib
Could Puma Biotech Double After This FDA Approval?
24/7 Wall St
Sun, 09/25/16 - 11:42 am
Puma Biotechnology
neratinib
3 Clinical-Stage Biotechs to Buy Ahead of FDA Decisions
Motley Fool
Wed, 09/21/16 - 10:59 pm
biotech
FDA
Aerie Pharma
Rhopressa
Flexion
Zilretta
Puma Biotechnology
neratinib
Puma Biotech Rises on Key FDA Approval
24/7 Wall St
Wed, 09/21/16 - 09:34 am
Puma Biotechnology
FDA
neratinib
breast cancer
Puma Biotech shares jump on breast cancer study, FDA application
Marketwatch
Thu, 07/21/16 - 09:08 pm
Puma Biotechnology
FDA
breast cancer
neratinib
5 Major Clinical Trial Results Coming Up
24/7 Wall St
Wed, 05/25/16 - 09:19 pm
clinical trials
Vertex Pharmaceuticals
Orkambi
Puma Biotechnology
neratinib
GW Pharma
Epidiolex
Agios Pharmaceuticals
AG-348
AG-519
Dermira
DRM-04

Pages